CBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
CRESCENT BIOPHARMA, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$12.36+0.52 (+4.39%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Crescent Biopharma's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 15, 2026 | Oct 15, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Jul 30, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 30, 2026 | Jul 30, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 14, 2026 | Jul 15, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 14, 2026 | Jul 14, 2026 | SEC EDGAR |
| Quarterly report, amended | 10-Q/A | Mar 31, 2026 | Jun 22, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 2, 2026 | Jun 3, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 29, 2026 | Apr 29, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | Apr 29, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 2, 2026 | Apr 21, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 26, 2026 | Feb 26, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 26, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 2, 2025 | Dec 4, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 29, 2025 | Jul 31, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Jul 31, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 13, 2025 | Jun 18, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 5, 2025 | Jun 6, 2025 | SEC EDGAR |
| Current report | 8-K | May 30, 2025 | May 30, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 14, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 28, 2025 | Apr 29, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 19, 2025 | Feb 25, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 14, 2025 | Feb 14, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 13, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 29, 2025 | Jan 31, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2025 | Jan 13, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 19, 2024 | Dec 26, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 13, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 7, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 28, 2024 | Oct 29, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 24, 2024 | Jul 30, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 21, 2024 | Jun 26, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 10, 2024 | Jun 13, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 4, 2024 | Jun 4, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 9, 2024 | SEC EDGAR |
| Current report | 8-K | May 6, 2024 | May 6, 2024 | SEC EDGAR |
| Current report | 8-K | May 1, 2024 | May 2, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | May 1, 2024 | Apr 1, 2024 | SEC EDGAR |